SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-028190
Filing Date
2024-09-03
Accepted
2024-09-03 06:01:22
Documents
18
Period of Report
2024-08-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bcda20240831_8k.htm   iXBRL 8-K 33217
2 EXHIBIT 1.1 ex_720357.htm EX-1.1 62173
3 EXHIBIT 4.1 ex_720358.htm EX-4.1 105536
4 EXHIBIT 4.2 ex_720359.htm EX-4.2 113239
5 EXHIBIT 99.1 ex_720360.htm EX-99.1 273336
  Complete submission text file 0001437749-24-028190.txt   834484

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bcda-20240829.xsd EX-101.SCH 3409
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bcda-20240829_def.xml EX-101.DEF 11424
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE bcda-20240829_lab.xml EX-101.LAB 15310
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bcda-20240829_pre.xml EX-101.PRE 11584
20 EXTRACTED XBRL INSTANCE DOCUMENT bcda20240831_8k_htm.xml XML 2812
Mailing Address 320 SOQUEL WAY SUNNYVALE CA 94085
Business Address 320 SOQUEL WAY SUNNYVALE CA 94085 650-226-0123
BioCardia, Inc. (Filer) CIK: 0000925741 (see all company filings)

IRS No.: 232753988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38999 | Film No.: 241271750
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)